StockData
Immuneering Corp logo

Immuneering Corp (IMRX) stock

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.46−0.06 (-1.70%)

Close on Nov 17, 2026Market cap $224.08MP/E –Yield –

Immuneering price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immuneering's price to book ratio was 1.2× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.4× to 8.0×, with a median of 1.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.2×+0.1
2025Dec 31, 20251.0×−0.1
2024Dec 31, 20241.1×−0.8
2023Dec 29, 20232.0×+0.9
2022Dec 30, 20221.0×+0.2
2021Dec 31, 20210.8×–

More Immuneering figures

See a number that looks wrong?